Association of prostaglandin E synthase 2 (PTGES2) Arg298His polymorphism with type 2 diabetes in two German study populations

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 8, 2007, Pages 3183-3188

  Nitz, Inke ^a   Fisher, Eva ^b   Grallert, Harald ^c   Li, Yun ^a   Gieger, Christian ^c,f   Rubin, Diana ^d   Boeing, Heiner ^b   Spranger, Joachim ^b   Lindner, Inka ^a   Schreiber, Stefan ^a   Rathmann, Wolfgang ^e   Gohlke, Henning ^c   Döring, Angela ^c   Wichmann, H Erich ^c,f   Schrezenmeir, Jürgen ^d   Döring, Frank ^a   Illig, Thomas ^c  

^a UNIVERSITY OF KIEL   (Germany)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

^e LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^f UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLUCOSE; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN E SYNTHASE 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GERMANY; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HOMOZYGOSITY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

EID: 34547790366     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2550     Document Type: Article

References (37)

1. Serhan CN, Levy B 2003 Success of prostaglandin E2 in structure-function is a challenge for structure-based therapeutics. Proc Natl Acad Sci USA 100:8609-8611
2. Murakami M, Kudo I 2004 Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway. Prog Lipid Res 43:3-35
3. Vassaux G, Gaillard D, Darimont C, Ailhaud G, Negrel R 1992 Differential response of preadipocytes and adipocytes to prostacyclin and prostaglandin E2: physiological implications. Endocrinology 131:2393-2398
4. Richelsen B 1991 Prostaglandins in adipose tissue - with special reference to triglyceride metabolism. Dan Med Bull 38:228-244
5. Richelsen B 1987 Factors regulating the production of prostaglandin E2 and prostacyclin (prostaglandin I2) in rat and human adipocytes. Biochem J 247:389-394
6. Chatzipanteli K, Rudolph S, Axelrod L 1992 Coordinate control of lipolysis by prostaglandin E2 and prostacyclin in rat adipose tissue. Diabetes 41:927-935
7. Richelsen B, Pedersen SB, Moller-Pedersen T, Bak JF 1991 Regional differences in triglyceride breakdown in human adipose tissue: effects of catecholamines, insulin, and prostaglandin E2. Metabolism 40:990-996
8. Borglum JD, Pedersen SB, Ailhaud G, Negrel R, Richelsen B 1999 Differential expression of prostaglandin receptor mRNAs during adipose cell differentiation. Prostaglandins Other Lipid Mediat 57:305-317
9. Marcus C, Sonnenfeld T, Karpe B, Bolme P, Arner P 1989 Inhibition of lipolysis by agents acting via adenylate cyclase in fat cells from infants and adults. Pediatr Res 26:255-259
10. Fain JN, Leffler CW, Bahouth SW, Rice AM, Rivkees SA 2000 Regulation of leptin release and lipolysis by PGE2 in rat adipose tissue. Prostaglandins Other Lipid Mediat 62:343-350
11. Fain JN, Leffler CW, Cowan Jr GS, Buffington C, Pouncey L, Bahouth SW 2001 Stimulation of leptin release by arachidonic acid and prostaglandin E(2) in adipose tissue from obese humans. Metabolism 50:921-928
12. Gaskins HR, Hausman DB, Martin RJ, Hausman GJ 1989 Evidence for abnormal prostaglandin synthesis in obese Zucker rat adipose cell cultures. J Nutr 119:458-462
13. Jakobsson PJ, Thoren S, Morgenstern R, Samuelsson B 1999 Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA 96:7220-7225
14. Murakami M, Naraba H, Tanioka T, Semmyo N, Nakatani Y, Kojima F, Ikeda T, Fueki M, Ueno A, Oh S, Kudo I 2000 Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 275:32783-32792
15. Gudis K, Tatsuguchi A, Wada K, Futagami S, Nagata K, Hiratsuka T, Shinji Y, Miyake K, Tsukui T, Fukuda Y, Sakamoto C 2005 Microsomal prostaglandin E synthase (mPGES)-1, mPGES-2 and cytosolic PGES expression in human gastritis and gastric ulcer tissue. Lab Invest 85:225-236
16. Murakami M, Nakashima K, Kamei D, Masuda S, Ishikawa Y, Ishii T, Ohmiya Y, Watanabe K, Kudo I 2003 Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2. J Biol Chem 278:37937-37947
17. Tanikawa N, Ohmiya Y, Ohkubo H, Hashimoto K, Kangawa K, Kojima M, Ito S, Watanabe K 2002 Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. Biochem Biophys Res Commun 291:884-889
18. Wilson AF, Elston RC, Tran LD, Siervogel RM 1991 Use of the robust sib-pair method to screen for single-locus, multiple-locus, and pleiotropic effects: application to traits related to hypertension. Am J Hum Genet 48:862-872
19. Fisher E, Nitz I, Lindner I, Rubin D, Boeing H, Mohlig M, Hampe J, Schreiber S, Schrezenmeir J, Doring F 2007 Candidate gene association study of type 2 diabetes in a nested case-control study of the EPIC-Potsdam cohort - role of fat assimilation. Mol Nutr Food Res 51:185-191
20. Boeing H, Korfmann A, Bergmann MM 1999 Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition. Ann Nutr Metab 43:205-215
21. Kroke A, Bergmann MM, Lotze G, Jeckel A, Klipstein-Grobusch K, Boeing H 1999 Measures of quality control in the German component of the EPIC study. European Prospective Investigation into Cancer and Nutrition. Ann Nutr Metab 43:216-224
22. Spranger J, Kroke A, Mohlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF 2003 Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52:812-817
23. Heidemann C, Hoffmann K, Spranger J, Klipstein-Grobusch K, Mohlig M, Pfeiffer AF, Boeing H 2005 A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC) - Potsdam Study cohort. Diabetologia 48:1126-1134
24. Wichmann HE GC, Illig T; MONICA/KORA Study Group 2005 KORA-gen - resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 67(Suppl 1):S46-S50
25. Rathmann W, Haastert B, Icks A, Lowel H, Meisinger C, Holle R, Giani G 2003 High prevalence of undiagnosed diabetes mellitus in southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 46:182-189
26. Weidinger S, Klopp N, Rummler L, Wagenpfeil S, Baurecht HJ, Gauger A, Darsow U, Jakob T, Novak N, Schafer T, Heinrich J, Behrendt H, Wichmann HE, Ring J, Illig T 2005 Association of CARD15 polymorphisms with atopyrelated traits in a population-based cohort of Caucasian adults. Clin Exp Allergy 35:866-872
27. Wabitsch M, Brenner RE, Melzner I, Braun M, Moller P, Heinze E, Debatin KM, Hauner H 2001 Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int J Obes Relat Metab Disord 25:8-15
28. Pritchard JK, Stephens M, Donnelly P 2000 Inference of population structure using multilocus genotype data. Genetics 155:945-959
29. Steffens M, Lamina C, Illig T, Bettecken T, Vogler R, Entz P, Suk EK, Toliat MR, Klopp N, Caliebe A, Konig IR, Kohler K, Ludemann J, Lacava AD, Fimmers R, Lichtner P, Ziegler A, Wolf A, Krawczak M, Nurnberg P, Hampe J, Schreiber S, Meitinger T, Wichmann HE, Roeder K, Wienker TF, Baur MP 2006 SNP-based analysis of genetic substructure in the German population. Hum Hered 62:20-29
30. Stram DO, Leigh Pearce C, Bretsky P, Freedman M, Hirschhorn JN, Altshuler D, Kolonel LN, Henderson BE, Thomas DC 2003 Modeling and E-M estimation of haplotype-specific relative risks from genotype data for a case-control study of unrelated individuals. Hum Hered 55:179-190
31. Hardy RJ, Thompson SG 1998 Detecting and describing heterogeneity in meta-analysis. Stat Med 17:841-856
32. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K 2002 A comprehensive review of genetic association studies. Genet Med 4:45-61
33. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, Balkau B, Heude B, Charpentier G, Hudson TJ, Montpetit A, Pshezhetsky AV, Prentki M, Posner BI, Balding DJ, Meyre D, Polychronakos C, Froguel P 2007 A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881-885
34. Meng ZX, Sun JX, Ling JJ, Lv JH, Zhu DY, Chen Q, Sun YJ, Han X 2006 Prostaglandin E(2) regulates Foxo activity via the Akt pathway: implications for pancreatic islet cell dysfunction. Diabetologia 49:2959-2968
35. Oshima H, Taketo MM, Oshima M 2006 Destruction of pancreatic β-cells by transgenic induction of prostaglandin E2 in the islets. J Biol Chem 281:29330-29336
36. Tran PO, Gleason CE, Poitout V, Robertson RP 1999 Prostaglandin E(2) mediates inhibition of insulin secretion by interleukin-1β. J Biol Chem 274:31245-31248
37. Sandra A, Marshall SJ 1986 Arachidonic acid inhibition of insulin action and phosphoinositide turnover in fat cells. Mol Cell Endocrinol 45:105-111